Ditchcarbon
  • Contact
  1. Organizations
  2. Cerus Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Cerus Corporation Sustainability Profile

Company website

Cerus Corporation, a leading biotechnology firm headquartered in the United States, has been at the forefront of blood safety and transfusion medicine since its founding in 1991. With a strong operational presence across North America and Europe, Cerus is dedicated to developing innovative solutions that enhance the safety of blood products. The company’s flagship product, the INTERCEPT Blood System, utilises advanced pathogen inactivation technology, setting it apart in the industry. This system significantly reduces the risk of transfusion-transmitted infections, making it a vital tool for healthcare providers. Cerus has achieved notable milestones, including regulatory approvals and partnerships that underscore its commitment to improving patient outcomes. As a pioneer in blood safety, Cerus Corporation continues to solidify its market position through ongoing research and development, ensuring the highest standards in transfusion practices.

DitchCarbon Score

How does Cerus Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Cerus Corporation's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Cerus Corporation's reported carbon emissions

Cerus Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Cerus Corporation's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, it is essential for companies like Cerus Corporation to establish clear emissions reduction targets and commitments to align with global climate goals and enhance sustainability practices.

How Carbon Intensive is Cerus Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cerus Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Cerus Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cerus Corporation is in US, which has a low grid carbon intensity relative to other regions.

Cerus Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Cerus Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Cerus Corporation's Emissions with Industry Peers

Terumo

JP
•
Health and social work services (85)
Updated 5 days ago

Maco Pharma International GmbH

DE
•
Health and social work services (85)
Updated 9 days ago

Haemonetics

US
•
Health and social work services (85)
Updated 9 days ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 16 hours ago

Grifols

ES
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Kedrion

IT
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251111.9
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy